ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2137 • 2013 ACR/ARHP Annual Meeting

    Important Predictors Of Patient-Reported Outcomes After TKR and THR Are Not Included In Risk Models Based On Administrative Data

    Patricia D. Franklin1, Leslie R. Harrold2, Wenjun Li1, Jeroan Allison3, David Ayers1 and Courtland Lewis4, 1Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 2University of Massachusetts Medical School, Worcester, MA, 3Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, 4Hartford Hospital, Hartford, CT

    Background/Purpose: Because total knee (TKR) and total hip (THR) replacement surgery is performed to relieve pain and improve physical function in patients with advanced arthritis,…
  • Abstract Number: 2139 • 2013 ACR/ARHP Annual Meeting

    Do Hyaluronic Acid Injections Delay Total Knee Replacement Surgery?

    Thomas Abbott1, Roy D. Altman2, Robert Dimeff3, Michael Fredericson4, Vijay Vad5, Peter Vitanzo Jr.6, Sashi Yadalam1, Ronald Levine1, Brad Bisson7 and Samir Bhattacharyya7, 1Johnson & Johnson, New Brunswick, NJ, 2David Geffen School of Medicine, UCLA, Los Angeles, CA, 3UT Southwestern Medical Center, Dallas, TX, 4Stanford University School of Medicine, Menlo Park, CA, 5Weill Cornell Medical College, NY, NY, 6Rothman Institute, Philadelphia, PA, 7DePuy Synthes Mitek Sports Medicine, Raynham, MA

    Background/Purpose:  More than 27 million adults in the US have knee osteoarthritis (OA), a painful and life-altering disease. Various non-pharmacologic and pharmacologic agents are recommended…
  • Abstract Number: 2140 • 2013 ACR/ARHP Annual Meeting

    Effects Of Intra-Articular Hyaluronic Acid Injections On Gait Pattern In Patients With Knee Osteoarthritis

    Bilal Uysal1, Aysegul Ketenci2, Sina Esmaeilzadeh2 and Dilsad Sindel2, 1Physical Medicine And Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Physical Medicine and Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: The aim of this study was to determine the effects of intra-articular hyaluronic acid (HA) injections on gait pattern of both injected and un-injected…
  • Abstract Number: 2141 • 2013 ACR/ARHP Annual Meeting

    Interphalangeal Intra-Articular Injection With Triamcinolone Hexacetonide: Assessment Of effectiveness  In Hand Osteoarthritis

    Natalia de Oliva Spolidoro1, Jamil Natour2, Rita N.V. Furtado3, Flavia S. Machado3 and Hilda A. Oliveira4, 1Rheumatology Division, Universidade Federal de São Paulo - Unifesp, São Paulo, Brazil, 2Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 4Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: Despite being a very prevalent joint condition, there is a lack of studies on the effectiveness of the intra-articular injection (IAI) of corticosteroids in…
  • Abstract Number: 2142 • 2013 ACR/ARHP Annual Meeting

    Long-Term Safety and Efficacy Of Subcutaneous Tanezumab In Patients With Knee Or Hip Osteoarthritis (NCT00994890)

    Leslie Tive1, Eugene J. Dabezies2, Robert J. Fountaine3, Mark T. Brown3, Michael D. Smith3, Kenneth M. Verburg3 and Christine R. West4, 1Arthritis, Pfizer Inc, New York, NY, 2Pensacola Research Consultants, Pensacola, FL, 3Pfizer, Inc., Groton, CT, 4Clinical Sciences, Pfizer, Williamston, MI

    Background/Purpose : Tanezumab (TNZ), a monoclonal antibody that inhibits nerve growth factor, reduces hip or knee osteoarthritis (OA) pain. A non-controlled, randomized, double-blind study of…
  • Abstract Number: 2143 • 2013 ACR/ARHP Annual Meeting

    Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate

    Olivier Bruyere1, Roland Chapurlat2, Cyrus Cooper3 and Jean-Yves Reginster1, 1Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, 2INSERM UMR 1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France, 3MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom

    Strontium ranelate significantly decreases radiological progression using a new definition for radiological progression in patients with primary knee osteoarthritis treated with strontium ranelate  Background/Purpose: Strontium…
  • Abstract Number: 2144 • 2013 ACR/ARHP Annual Meeting

    Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate

    Jean-Yves Reginster1, Roland Chapurlat2, Francis Berenbaum3, P. Nash4, O. Zamani5, Martine Cohen-Solal6, Gerolamo Bianchi7, Jaime Branco8, F. Navarro9 and Cyrus Cooper10, 1Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, 2INSERM UMR 1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France, 3Rheumatology, AP-HP, St Antoine Hospital, Paris, France, 4University of Queensland, Brisbane, Australia, 5Rheumazentrum Favoriten, Wien, Austria, 6Rhumatologie A, INSERM U606 Hôpital Lariboisière, Centre Viggo Petersen, Paris, France, 7Div Reumatologia, ASL3 Genovese, Genoa, Italy, 8UNL/Rheumatology Department, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, 9UGC de Reumatologia, University Hospital Virgen Macarena, Sevilla, Spain, 10MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom

    Prevention of radiological progression in patients with primary knee osteoarthritis  with Strontium Ranelate Background/Purpose: Strontium ranelate (SrRan) has demonstrated a structure-modifying activity with symptomatic improvement in…
  • Abstract Number: 2145 • 2013 ACR/ARHP Annual Meeting

    Impact On Cartilage Volume Changes Over Time Of Conventional Treatment and Of Glucosamine and Chondroitin Sulfate In Knee Osteoarthritis Patients: Data From The Osteoarthritis Initiative Cohort

    Johanne Martel-Pelletier1, Camille Roubille1, Jean-Pierre Raynauld1, François Abram2, Pierre Dodin3, Marc Dorais4, Philippe Delorme1 and Jean-Pierre Pelletier1, 1Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 2Medical Imaging Research & Development, ArthroLab Inc., Montreal, QC, Canada, 3Imaging Research & Development, ArthroLab Inc., Montreal, QC, Canada, 4StatSciences Inc., Notre-Dame de l’Île Perrot, QC, Canada

    Background/Purpose: To explore, using data from participants enrolled in the progression cohort of the Osteoarthritis Initiative (OAI), the effects of conventional knee osteoarthritis (OA) pharmacological…
  • Abstract Number: 2146 • 2013 ACR/ARHP Annual Meeting

    Effects Of Chondroitin Sulfate On Brain Response To Painful Stimulation In Knee Osteoarthritis Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    Jordi Monfort1, Jesús Pujol2, O Contreras-Rodriguez2, Jone Llorente-Onaindia2, M López-Solà2, Laura Blanco-Hinojo2, J Deus2, H Ortiz2, Francisco Montañés3, M Campillo2, Pere Benito2, Laura Sánchez4, Marta Herrero5 and Josep Vergés6, 1Reumatologia, Hospital del Mar, Barcelona, Spain, 2Hospital del Mar, Barcelona, Spain, 3Rhaumatology, Hospital del Mar, Barcelona, Spain, 4Bioiberica, Barcelona, Spain, 5Pharmascience Division, Bioiberica S.A., Barcelona, Spain, 6Pre-Clinical R&D Area, Pharmascience Division, BIOIBERICA S.A., Barcelona, Spain

    Background/Purpose:  Knee osteoarthritis (OA) is a degenerative joint disease causing symptoms in 12% of people over the age of 65 . A variety of treatments…
  • Abstract Number: 2147 • 2013 ACR/ARHP Annual Meeting

    Effect Of Fish Oil On Structural Progression In Knee Osteoarthritis: A Two Year Randomized, Double-Blind Clinical Trial Comparing High Dose With Low Dose

    Catherine L. Hill1, Graeme Jones2, Susan Lester3, Ruth Battersby1, Tanya Fedorova4, Kristen Hynes5, Susanna Proudman6, Leslie G. Cleland6 and Lyn March7, 1Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, 2Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, 3Rheumatology Unit, Queen Elizabeth Hospital, Woodville South, Australia, 4Rheumatology Royal North Shore Hospital, University of Sydney Institute of Bone and Joint Research, St Leonards, Australia, 5Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia, 6Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, 7Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia

    Background/Purpose: Fish oil is widely used for the symptomatic treatment of osteoarthritis.  However, its effect on cartilage volume has not previously been investigated in an…
  • Abstract Number: 2148 • 2013 ACR/ARHP Annual Meeting

    Use Of Low Dose Aspirin Is Associated With Reduced Medial Tibial Cartilage Loss In Symptomatic Osteoarthritis: DATA From A Cohort Study

    Anita Wluka1, Changhai Ding2, Yuanyuan Wang3, Graeme Jones4, Andrew Teichtahl5 and Flavia Cicuttini1, 1Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, 2Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, 3Monash University, Melbourne, Australia, 4Menzies Research Institute Tasmania, University of Tasmania, HOBART, Australia, 5Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia

    Background/Purpose: Inflammation and vascular disease have recently been shown to play a role in the pathogenesis of osteoarthritis (OA). Low dose aspirin is commonly used…
  • Abstract Number: 2125 • 2013 ACR/ARHP Annual Meeting

    Comparison Of The Effectiveness Of Local Anesthetic and Corticosteroid Injections For The Treatment Of Piriformis Syndrome

    Tugce Ozekli Misirlioglu, Kenan Akgun, Meryem Gul Erden and Tuba Erbilir, Physical Medicine and Rehabilitation, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey

    Background/Purpose: Piriformis syndrome (PS), which is characterized by pain radiating to gluteal region and posterior leg, is accepted as one of the causes of sciatica.…
  • Abstract Number: 2109 • 2013 ACR/ARHP Annual Meeting

    Quality Indicators For Physical Therapy Management In Hip and Knee Osteoarthritis and Rheumatoid Arthritis

    Wilfred FH Peter1,2, Emalie Hurkmans3, Philip van der Wees4, Erik Hendriks5, Rob de Bie5, Leti van Bodegom-Vos6 and Theodora P.M. Vliet Vlieland7, 1Departmentof Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, 2Amsterdam Rehabilitation Research Center, Reade, centre for rehabilitation and rheumatology, Amsterdam, Netherlands, 3Section Physiotherapy, University of Applied Sciences, Vienna, Austria, 4IQ Healthcare, Radboud University, Nijmegen, Netherlands, 5Centre for Evidence Based Physiotherapy, University of Maastricht, Maastricht, Netherlands, 6Department of Medical Decision Making, Leiden University Medical Center, Leiden, Netherlands, 7Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Physical therapy is recommended in several guidelines on the management of osteoarthritis and rheumatoid arthritis.  Currently, no specific quality indicators for physical therapy in…
  • Abstract Number: 2110 • 2013 ACR/ARHP Annual Meeting

    Who Will Achieve Individually Set Goals After Arthritis Team Rehabilitation?

    Sofia Hagel1, Elisabet Lindqvist2 and Ann B. I. Bremander3, 1Department of Clinical Sciences Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, 2Department of Clinical Sciences, Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, 3Department of Clinical Sciences, Lund, Section of Rheumatology, Lund, Lund University, Lund, Sweden

    Background/Purpose: To study goal achievement among patients with chronic inflammatory arthritis after arthritis rehabilitation performed in multidisciplinary team rehabilitation programs. Methods: 146 consecutive patients with…
  • Abstract Number: 2111 • 2013 ACR/ARHP Annual Meeting

    The Impact Of Centralized Pain On Long-Term Analgesic Response To Lower Extremity Joint Arthroplasty:  A Prospective, Observational Cohort Study

    Chad M. Brummett1, Andrew Urquhart2, Brian Hallstrom2, Alex Tsodikov3, David A. Williams4 and Daniel J. Clauw5, 1Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, 2Orthopedics, University of Michigan Health System, Ann Arbor, MI, 3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, 4Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI, 5Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI

    Background/Purpose :  In cross-sectional studies, depression and pain in other locations have been reported as predicting poorer outcomes following total knee and hip arthroplasty.  These…
  • « Previous Page
  • 1
  • …
  • 2107
  • 2108
  • 2109
  • 2110
  • 2111
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology